Alec Stranahan
Stock Analyst at B of A Securities
(0.87)
# 3,700
Out of 4,761 analysts
28
Total ratings
42.11%
Success rate
-22.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics | Initiates: Buy | $15 | $11.63 | +28.98% | 1 | Feb 7, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $28 → $25 | $12.43 | +101.13% | 4 | Jan 7, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $13 → $11 | $1.31 | +739.69% | 1 | Jan 7, 2025 | |
| ERAS Erasca | Upgrades: Buy | $5 | $1.41 | +254.61% | 2 | Jan 7, 2025 | |
| CATX Perspective Therapeutics | Downgrades: Neutral | $24 → $6 | $2.78 | +115.83% | 2 | Nov 25, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $48 → $55 | $41.34 | +33.04% | 3 | Jul 16, 2024 | |
| NVAX Novavax | Maintains: Neutral | $12 → $18 | $7.99 | +125.28% | 3 | Jun 14, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $118 → $140 | $187.86 | -25.48% | 3 | May 25, 2023 | |
| XNCR Xencor | Initiates: Buy | $42 | $15.74 | +166.84% | 1 | May 19, 2023 | |
| YMAB Y-mAbs Therapeutics | Maintains: Neutral | $6 → $12 | $5.72 | +109.79% | 4 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $5 → $6 | $30.88 | -80.57% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $60 → $5 | $1.78 | +180.90% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $58.25 | -22.75% | 1 | Dec 1, 2022 |
Candel Therapeutics
Feb 7, 2025
Initiates: Buy
Price Target: $15
Current: $11.63
Upside: +28.98%
Day One Biopharmaceuticals
Jan 7, 2025
Maintains: Buy
Price Target: $28 → $25
Current: $12.43
Upside: +101.13%
Caribou Biosciences
Jan 7, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $1.31
Upside: +739.69%
Erasca
Jan 7, 2025
Upgrades: Buy
Price Target: $5
Current: $1.41
Upside: +254.61%
Perspective Therapeutics
Nov 25, 2024
Downgrades: Neutral
Price Target: $24 → $6
Current: $2.78
Upside: +115.83%
Revolution Medicines
Jul 16, 2024
Maintains: Buy
Price Target: $48 → $55
Current: $41.34
Upside: +33.04%
Novavax
Jun 14, 2024
Maintains: Neutral
Price Target: $12 → $18
Current: $7.99
Upside: +125.28%
Krystal Biotech
May 25, 2023
Maintains: Buy
Price Target: $118 → $140
Current: $187.86
Upside: -25.48%
Xencor
May 19, 2023
Initiates: Buy
Price Target: $42
Current: $15.74
Upside: +166.84%
Y-mAbs Therapeutics
May 15, 2023
Maintains: Neutral
Price Target: $6 → $12
Current: $5.72
Upside: +109.79%
Dec 29, 2022
Maintains: Underperform
Price Target: $5 → $6
Current: $30.88
Upside: -80.57%
Dec 2, 2022
Downgrades: Underperform
Price Target: $60 → $5
Current: $1.78
Upside: +180.90%
Dec 1, 2022
Initiates: Buy
Price Target: $45
Current: $58.25
Upside: -22.75%